Literature DB >> 25068996

FOXM1: A key oncofoetal transcription factor in health and disease.

Laura Bella1, Stefania Zona1, Gabriela Nestal de Moraes1, Eric W-F Lam2.   

Abstract

Forkhead Box M1 (FOXM1) is a bona fide oncofoetal transcription factor, which orchestrates complex temporal and spatial gene expression throughout embryonic and foetal development as well as during adult tissue homeostasis and repair. Controlled FOXM1 expression and activity provides a balanced transcriptional programme to ensure proper growth and maturation during embryogenesis and foetal development as well as to manage appropriate homeostasis and repair of adult tissues. Conversely, deregulated FOXM1 upregulation likely affects cell migration, invasion, angiogenesis, stem cell renewal, DNA damage repair and cellular senescence, which impact tumour initiation, progression, metastasis, angiogenesis and drug resistance. A thorough understanding of the regulation and role of FOXM1 in health and in cancer should contribute to the development of better diagnostics and treatments for cancer as well as congenital disorders and other developmental diseases.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Development; FOXM1; Oncofoetal protein; Transcription factor

Mesh:

Substances:

Year:  2014        PMID: 25068996     DOI: 10.1016/j.semcancer.2014.07.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  63 in total

Review 1.  Targeting forkhead box M1 transcription factor in breast cancer.

Authors:  Ruth M O'Regan; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2018-05-31       Impact factor: 5.858

2.  A FOXM1 related long non-coding RNA contributes to gastric cancer cell migration.

Authors:  Hui Cai; Jingde Chen; Bin He; Qiang Li; Yandong Li; Yong Gao
Journal:  Mol Cell Biochem       Date:  2015-04-24       Impact factor: 3.396

3.  Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.

Authors:  Meng Yue; Shiquan Li; Guoqiang Yan; Chenyao Li; Zhenhua Kang
Journal:  Cell Cycle       Date:  2018-01-05       Impact factor: 4.534

4.  Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.

Authors:  Vaibhav Chand; Akshay Pandey; Dragana Kopanja; Grace Guzman; Pradip Raychaudhuri
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

5.  Effect of lifelong football training on the expression of muscle molecular markers involved in healthy longevity.

Authors:  A Mancini; D Vitucci; G Labruna; E Imperlini; M B Randers; J F Schmidt; M Hagman; T R Andersen; R Russo; S Orrù; P Krustrup; F Salvatore; P Buono
Journal:  Eur J Appl Physiol       Date:  2017-03-01       Impact factor: 3.078

6.  Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.

Authors:  Jin Yang; Xuhui Feng; Qiong Zhou; Wei Cheng; Ching Shang; Pei Han; Chiou-Hong Lin; Huei-Sheng Vincent Chen; Thomas Quertermous; Ching-Pin Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

7.  Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells.

Authors:  Xinping Yang; Yuanyuan Shi; Jingzhe Yan; Haitao Fan
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

Review 8.  Forkhead box M1 transcription factor: a novel target for pulmonary arterial hypertension therapy.

Authors:  Li Gu; Han-Min Liu
Journal:  World J Pediatr       Date:  2019-06-12       Impact factor: 2.764

9.  MiR-28-5p promotes human glioblastoma cell growth through inactivation of FOXO1.

Authors:  Guohua Zhu; Zengliang Wang; Maimaitili Mijiti; Guojia Du; Yandong Li; Geng Dangmurenjiafu
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

Review 10.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.